En busca de la evidencia perdida. Propuestas para incrementar la transparencia de los ensayos clínicos

Medicina Clinica

Volumn 112, Issue SUPPL. 1, 1999, Pages 21-27

  Urrutia, Gerard ^a,b   Bonfill, Xavier ^c   Martí, Joan ^c  

^a Secretario Comite Etico Invest C   (Spain)

^b Inst Universitari Fundacio Parc T   (Spain)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; EVIDENCE BASED MEDICINE; HUMAN; INTERNATIONAL COOPERATION; LEGAL ASPECT; MANAGEMENT; METHODOLOGY; PROFESSIONAL STANDARD; PUBLISHING; RESEARCH; REVIEW; STANDARD;

CLINICAL TRIALS; ETHICS COMMITTEES; EVIDENCE-BASED MEDICINE; HUMANS; INTERNATIONAL COOPERATION; POLICY MAKING; PUBLISHING; RESEARCH;

EID: 0033253035     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Office of Technology Assessment. The impact of randomized clinical trials on health policy and medical practice. Background paper Washington D.C.: US Congress, 1983.
2. Porta M, Ibáñez I, Carné X, Laporte JR. Principios del ensayo clinico. Med Clin (Barc) 1983; 80: 768-770.
3. Hulley SB, Cummings SR. Diseño de la investigación cllnica. Un enfoque epidemiológico. Barcelona: Doyma, 1993.
4. Bakke OM, Carné X, García Alonso F. Ensayos clínicos con medicamentos. Fundamentes básicos, metodología y práctica. Barcelona: Doyma, 1994.
5. Sackett DL, Richardson WS, Rosenberg W, Haynes RB. Medicina basada en la evidencia. Cómo ejercer y enseñar la MBE. Madrid: Churchill Livingstone, 1997.
6. Dickersin K. The existence of publication bias and risk factors for its occurrence. JAMA 1990; 263: 1.885-1.889.
7. Ioannidis JP, Cappelleri JC, Sacks HS, Lau J. The relationship between study design, results, and reporting of randomized clinical trials HIV infection. Control Clin Trials 1997; 18: 431-444.
8. Stern JM, Simes RJ. Publication bias: evidence of delayed publication in a cohort study of clinical research projects. Br Med J 1997; 315: 640-645.
9. Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR. Publication bias in clinical research. Lancet 1991; 337: 867-872.
10. Moscati R, Jehle D, Ellis D, Fiorello A, Landi M. Positive-outcome bias: comparison of emergency medicine and general medicine literatures. Acad Emerg Med 1994; 1: 267-271.
11. Dickersin K, Min YI. NIH clinical trials and publication bias. Online J Curr Clin Trials 1993; Apr 28; Doc No. 50.
12. Dickersin K, Chan S, Chalmers TC, Sacks HS, Smith H Jr. Publication bias and clinical trials. Control Clin Trials 1987; 8: 33-53.
13. Chalmers I, Adams M, Dickersin K, Hetherington J, Tarnow-Mordi W, Meiner C et al. A cohort study of summary reports of controlled trials. JAMA 1990; 263: 1.401-1.405.
14. Chalmers TC, Frack CS, Reitman D, Minimizing the three stages of publications bias JAMA 1990; 263: 1.392-1.395.
15. Begg CB, Berlin JA. Publication bias: a problem in interpreting medical data. J Roy Stat Soc A 1988; 151: 419-463.
16. Begg CB, Berlin JA. Publication bias and dissemination of clinical research. J Natl Cancer Inst 1989; 81: 107-115.
17. Berlin JA, Begg CB, Louis TA. An assessment of publication bias using a sample of published clinical trials. J Am Stat Assoc 1989; 84: 381-392.
18. Simes RJ. Confronting publication bias: a cohort design for meta-analysis. Stat Med 1987; 6: 11-29.
19. Simes RJ. Publication bias: the case for an international registry of clinical trials. J Clin Oncol 1986; 4: 1.529-1.541.
20. Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR. Publication bias in clinical research. Lancet 1991; 337: 867-872.
21. Dickersin K, Min YI, Meinert CL. Factors influencing publication of research results. JAMA 1992; 267: 374-378.
22. Dickersin K, Min YI. NIH clinical trials and publication bias. Online J Curr Clin Trials 1993 Apr 28; Doc No. 50.
23. National Institute of Health inventory of clinical trials: fiscal year 1979.
24. Meinert CL. Toward prospective registration of clinical trials. Control Clin Trials 1988; 9: 1-5.
25. Dickersin K. Report from the panel on the case for registers of clinical trials at the eighth Annual Meeting of the Society for Clinical Trials. Control Clin Trials 1988; 9: 76-81.
26. Dickersin K. Why register clinical trials? Control Clin Trials 1992; 13: 170-177.
27. Real Decreto 561/1993, de 16 de abril, por el que se establecen los requisitos para la realización de ensayos cllnicos con medicamentos.
28. Moher D, Jadad AR, Tugwell P, Assessing the quality of randomized controlled trials: current issues and future directions. Int J Technol Assess Health Care 1996; 12: 195-208.
29. Liberati A, Himel HN, Chalmers TC. A quality assessment of randomized control trials of primary treatment of breast cancer. J Clin Oncol 1986; 4: 942-951.
30. Simon R, Wittes RE. Methodologic guidelines for reports of clinical trials. Cancer Treatment Reports 1985; 69: 1-3.
31. Grant A. Reporting controlled trials. Br J Obstet Gynaecol 1989; 96: 397-400.
32. Zelen M. Guidelines for publishing papers on cancer clinical trials: responsabilities of editors and authors. J Clin Oncol 1983; 1: 154-169.
33. Mosteller F, Gilbert JP, McPeek B. Reporting standards and research strategies for controlled trials. Control Clin Trials 1980; 1: 37-58.
34. Gardner MJ, Machin D, Campdell MJ. Use of checklists in assessing the statistical content of medical studies. Br Med J 1986; 292: 810-812.
35. Gore SM, Jones G, Thompson SG. The Lancet's statistical review process: areas for improvement by authors. Lancet 1992; 340: 100-102.
36. Schulz KF, Chalmers I, Grimes DA, Altman DG. Assessing the quality of randomization from reports of controlled trials published in obstetrics and gynecology journals JAMA 1994; 272: 125-128.
37. Mahon WA, Daniel EE. A method for the assessment of reports of drug trials. Can Med Assoc J 1964; 90: 565-569.
38. Pocock SJ, Hughes MD, Lee RJ. Statistical problems in the reporting of clinical trials. N Engl J Med 1987; 317: 426-432.
39. Altman DG, Doré CJ. Randomization and baseline comparisons in clinical trials. Lancet 1990; 335: 149-153.
40. Gotzsche PC. Methodology and overt and hidden bias in reports of 196 double-blind trials of nonsteroidal antiinflammatory drugs in rheumatoid arthritis. Control Clin Trials 1989; 10: 31-56.
41. Solomon MJ, McLeod RS. Clinical studies in surgical journals: have we improved? Dis Colon Rectum 1993; 36: 43-48.
42. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995; 273: 408-412.
43. Ad Hoc Working Group for Critical Appraisal of the Medical Literature. A proposal for more informative abstracts of clinical articles. Ann Intern Med 1987; 106: 598-604.
44. Haynes RB, Mulrow CD, Huth EJ, Altman DG, Gardner MJ. More informative abstracts revisited. Ann Intern Med 1990; 113: 69-76.
45. Taddio A, Pain T, Fassos FF, Boon H, Ilersich AL, Einarson TR. Quality of nonstructured and structured abstracts of original research articles in the British Medical Journal, the Canadian Medical Association Journal and the Journal of the American Medical Association. Can Med Assoc J 1994; 150: 1.611-1.615.
46. Rennie D. Reporting randomized controlled trials: an experiment and a call for responses from readers. JAMA 1995; 273: 1.054-1.055.
47. Begg C, Cho M, Eastwood S et al. Improving the quality of reporting of randomized controlled trials: the CONSORT statement. JAMA 1996; 276: 637-639.
48. Fletcher RH, Fletcher SW. Clinical research in general medical journals: a 30-year perspective. N Engl J Med 1979; 301: 180-183.
49. Rennie D. How to report randomized controlled trials: the CONSORT statement. JAMA 1996; 276: 649.
50. Altman DJ. Better reporting of randomised controlled trials: the CONSORT statement. Br Med J 1996; 313: 570-571.
51. McNamee D, Horton R. Lies, damn lies, and reports of randomised controlled trials. Lancet 1996; 348: 562.
52. Huston P, Hoey J. CMAJ endorses the CONSORT statement. Can Med Assoc J 1996; 155: 1.277-1.279.
53. Chalmers I. Underreporting research is scientific misconduct. JAMA 1990; 263: 1.405-1.408.
54. Munro AJ. Publishing the findings of clinical research. Br Med J 1993; 307: 1.340-1.341.
55. Pearn J. Publication: an ethical imperative. Br Med J 1995; 310: 1.313-1.315
56. Whitaker VB, Whitaker R Jr. Ethics: issues of concern. Insight 1991; 16: 30-31.
57. Jongen PJ. Data handling in clinical trials: an ongoing debate. Mult Scler 1995; 1 (Supl 1): 60-63.
58. Horton R. Medical editors trial amnesty. Lancet 1997; 350: 756.